B-Type Natriuretic Peptide(BNP)ab
Desired Epic Build
* = editable field
| Cerner Primary Mnemonic: | B-Type Natriuretic Peptide(BNP)ab | ||||||
| PDM | 235312 | ||||||
| Informatics - Workgroup | Chemistry | ||||||
| Synonyms * | B-Type Natriuretic Peptide(BNP)ab BNP | ||||||
| Display Name * | B-Type Natriuretic Peptide(BNP)ab | ||||||
| Specimen Sources (combined Order Entry and Specimen Navigator) * | |||||||
| Specimen Types (combined Order Entry and Specimen Navigator) * | |||||||
| Body Fluids (types sent through AOEs) | |||||||
| Specimen Navigator Specimen Types | |||||||
| Specimen Navigator Specimen Sources | |||||||
| Specimen Navigator Short Name | |||||||
| Ordering info (EPIC SmartText) | Support a diagnosis of congestive heart failure (CHF) B-type natriuretic peptide (BNP), also referred to as brain natriuretic peptide, is a member of a family of structurally similar peptide hormones that includes atrial natriuretic peptide.1 BNP is a 32-amino-acid peptide that contains a 17-amino-acid ring structure that is formed as the result of an internal disulfide bond. BNP is predominantly secreted by the ventricles of the heart in response to increased pressure. BNP acts as a vasodilator and has diuretic and natriuretic properties. BNP suppresses both sympathetic tone and the renin-angiotensin system. These physiologic effects serve to reduce intraventricular pressure and improve the symptoms of congestive heart failure (CHF). BNP levels increase with age and can be transiently increased by vigorous exercise.1,2 BNP levels correlate with end-diastolic pressure and tend to be increased in patients with diminished left ventricular ejection fraction.1,3 BNP levels have been shown to be useful in the diagnosis of patients with symptoms that are consistent with CHF. Maisel and coworkers4 found that a BNP cutoff of 75 pg/mL could be used to predict systolic and/or diastolic abnormalities accurately in symptomatic patients referred to echocardiology for left ventricular function studies. They found that this cutoff identified patients with abnormal function from a population of 200 patients with a sensitivity of 95.9%, specificity of 86%, positive predictive value of 98%, and a negative predictive value of 89%. The overall accuracy of the diagnosis with a cutoff of 75 pg/mL was 93%. These results were similar to those found by Dao and coworkers.5 They found that BNP levels could be used to accurately identify patients with CHF from a population of patients presenting at the emergency room with shortness of breath (dyspnea). They found that a BNP value >80 pg/mL could be used to identify patients with CHF from this population with a sensitivity of 97%, specificity of 98%, positive predictive value of 92%, and a negative predictive value of 98%.6 Footnotes 1. Maisel A. B-type natriuretic peptide levels: A potential novel “white count” for congestive heart failure. J Card Fail. 2001; 7(2):183-193. PubMed 11420771 2. McNairy M, Gardetto N, Clopton P, et al. Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: Implications for outpatient monitoring with B-type natriuretic peptide. Am Heart J. 2002; 143(3):406-411. PubMed 11868044 3. Valli N, Georges A, Corcuff JB, et al. Assessment of brain natriuretic peptide in patients with suspected heart failure: Comparison with radionuclide ventriculography data. Clin Chim Acta. 2001; 306(1-2):19-26. PubMed 11282090 4. Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J. 2001; 141(3):367-374. PubMed 11231433 5. Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol. 2001; 37(2):379-385. PubMed 11216950 6. Wu AH, Packer M, Smith A et al. Analytical and clinical evaluation of the Bayer ADVIA Centaur Automated B-type natriuretic peptide assay in patients with heart failure: A multisite study. Clin Chem. 2004 May; 50(5):867-873. | ||||||
| IP Orderable (inpatient) | No | ||||||
| OP Orderable (outpatient) | No | ||||||
| AOEs * | |||||||
| AP AOEs | |||||||
| Special History | No | ||||||
| Build Comments | |||||||
| Filter * | |||||||
| Cerner Site Restrict | Forest Hills Hospital Laboratory Huntington Hospital Laboratory LabCorp Northwell Health Laboratories Plainview Hospital Laboratory SIUH North Laboratory SIUH Pouch Terminal Laboratory | ||||||
Cerner Results
| |||||||
Actual Epic Build 3/11/2025
| PROCEDURE ID | 183364 | ||||||||||||
| PDM | 235312 | ||||||||||||
| ORDER DISPLAY NAME | B-Type Natriuretic Peptide(BNP) ab | ||||||||||||
| PROCEDURE NAME | B-TYPE NATRIURETIC PEPTIDE(BNP) AB | ||||||||||||
| PROCEDURE MASTER NUMBER | LAB14064 | ||||||||||||
| SHORT PROCEDURE NAME | B-TYPE NATRIURETIC PEPTIDE(BNP) AB | ||||||||||||
| CATEGORY CODE | 1.0 | ||||||||||||
| CATEGORY CODE RECORD NAME | LAB BLOOD ORDERABLES | ||||||||||||
| SYNONYMS | B-Type Natriuretic Peptide(BNP)ab BNP |
||||||||||||
| CLINICALLY ACTIVE | No | ||||||||||||
| ORDERABLE | No | ||||||||||||
| PERFORMABLE | Yes | ||||||||||||
| FILTER GENOMICS | |||||||||||||
| REFERENCE LINK URL | |||||||||||||
| ORDERING INSTRUCTIONS | |||||||||||||
| DEFAULT SPECIMEN TYPE | |||||||||||||
| SPECIMEN TYPE PICK LIST | |||||||||||||
| SPECIMEN TYPE LIST | |||||||||||||
| OP SPECIMEN TYPE LIST | |||||||||||||
| SPECIMEN SOURCE PICK LIST | |||||||||||||
| SPECIMEN SOURCE DEFAULT - MALE | |||||||||||||
| SPECIMEN SOURCE DEFAULT - FEMALE | |||||||||||||
| SPECIMEN SOURCE LIST | |||||||||||||
| OP SPECIMEN SOURCE LIST | |||||||||||||
| IP LAB TEST COMPONENTS FOR REPORT | BNP | ||||||||||||
| OP LAB TEST COMPONENTS FOR REPORT | BNP | ||||||||||||
| ORDER QUESTIONS | [] | ||||||||||||
| ORDER QUESTIONS RECORD NAME | |||||||||||||
| INPATIENT ORDER QUESTIONS | [] | ||||||||||||
| INPATIENT ORDER QUESTIONS RECORD NAME | |||||||||||||
| ORDER SPECIFIC QUESTION OVERRIDE | |||||||||||||
| INPATIENT QUESTION OVERRIDE | |||||||||||||
| LOCATION RESTRICT LIST IP | |||||||||||||
| LOCATION RESTRICT LIST IP RECORD NAME | |||||||||||||
| LOCATION RESTRICT LIST INCLUDE IP | |||||||||||||
| LOCATION RESTRICT LIST OP | |||||||||||||
| LOCATION RESTRICT LIST OP RECORD NAME | |||||||||||||
| LOCATION RESTRICT LIST INCLUDES OP | |||||||||||||
| EDP AMB ORDER SPECIFIC QUESTIONS RECORD NAME | |||||||||||||
| EDP IP ORDER SPECIFIC QUESTIONS RECORD NAME | |||||||||||||
| EDP IP SPECIMEN SOURCE | Blood, Venous Blood, Central Line Blood, Arterial Blood, Capillary |
||||||||||||
| EDP OP SPECIMEN SOURCE | |||||||||||||
| EDP IP SPECIMEN TYPE | Blood | ||||||||||||
| EDP OP SPECIMEN TYPE | |||||||||||||
| DERIVED EDP IP BUTTONS S | |||||||||||||
| DERIVED EDP IP BUTTONS T | |||||||||||||
| DERIVED EDP OP BUTTONS S | |||||||||||||
| DERIVED EDP OP BUTTONS T | |||||||||||||
| IP ORDERABLE | |||||||||||||
| OP ORDERABLE | |||||||||||||
| STANDARD LAB COMPONENTS | |||||||||||||
| STANDARD LAB COMPONENTS RECORD NAME | |||||||||||||
| COMPONENT DATA REQUIREMENT | |||||||||||||
| EPIC OP AOEs | |||||||||||||
| EPIC IP AOEs | |||||||||||||
EPIC Components (results - crosswalked through Cerner)
| |||||||||||||